Abstract
The only efficacious therapy available for patients with acute ischemic stroke is intravenous (IV) alteplase, when used up to 4.5 hours after symptom onset. However, only half of patients who receive thrombolytic therapy achieve recanalization, and only half of these have good long-term outcomes. No highly validated methodologies allow acute identification of patients who are most likely to have dismal outcomes despite thrombolysis, independent of hemorrhage. To develop an easy, practical scoring system using variables known to be associated with poor outcome, European researchers analyzed admission clinical data from patients who received thrombolysis …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
